Addus HomeCare (NASDAQ:ADUS) Issues Quarterly Earnings Results, Beats Estimates By $0.04 EPS

Addus HomeCare (NASDAQ:ADUS) issued its quarterly earnings data on Tuesday. The company reported $1.83 earnings per share for the quarter, topping the consensus estimate of $1.79 by $0.04, FiscalAI reports. The company had revenue of $387.74 million for the quarter, compared to analysts’ expectations of $388.72 million. Addus HomeCare had a net margin of 7.39% and a return on equity of 10.37%. Addus HomeCare’s revenue for the quarter was up 7.0% on a year-over-year basis. During the same quarter in the previous year, the firm posted $1.56 earnings per share.

Addus HomeCare Price Performance

Shares of ADUS opened at $127.94 on Thursday. The company has a current ratio of 1.69, a quick ratio of 1.69 and a debt-to-equity ratio of 0.05. The firm’s fifty day simple moving average is $117.35 and its 200-day simple moving average is $106.71. The firm has a market capitalization of $2.39 billion, a price-to-earnings ratio of 21.32, a PEG ratio of 1.80 and a beta of 0.75. Addus HomeCare has a twelve month low of $87.95 and a twelve month high of $130.40.

Analyst Upgrades and Downgrades

A number of research analysts have commented on ADUS shares. Truist Financial set a $148.00 price target on Addus HomeCare in a research report on Thursday. Barclays increased their target price on shares of Addus HomeCare from $96.00 to $101.00 and gave the company an “underweight” rating in a research note on Wednesday. Bank of America downgraded Addus HomeCare from a “buy” rating to a “neutral” rating and decreased their price objective for the company from $140.00 to $125.00 in a report on Monday, September 14th. Royal Bank Of Canada lifted their price objective on shares of Addus HomeCare from $130.00 to $134.00 and gave the stock an “outperform” rating in a research report on Wednesday, August 5th. Finally, Raymond James Financial set a $137.00 target price on Addus HomeCare in a research report on Monday, September 28th. One research analyst has rated the stock with a Strong Buy rating, four have given a Buy rating, four have given a Hold rating and one has given a Sell rating to the stock. According to MarketBeat, the company presently has a consensus rating of “Moderate Buy” and an average price target of $130.25.

Addus HomeCare Company Profile

Addus HomeCare Inc (NASDAQ: ADUS) provides in-home personal care, hospice and home health services to older adults, people with disabilities and other individuals who need assistance with daily living or medical care. Its services are designed to help clients remain safely and independently in their homes while supporting families and caregivers.

The company’s personal care services include assistance with bathing, dressing, grooming, meal preparation, housekeeping and other activities of daily living.